Procter & Gamble Company (The) Dossier

Procter & Gamble Company (The) reported fiscal year 2025 net sales of $84.3 billion and generated net earnings of $14.1 billion, performance driven by equal contributions from pricing actions and organic volume growth. The corporation maintained stable execution across its global markets, leveraging a portfolio of daily-use products to deliver consistent shareholder value. With operating cash flow reaching $17.8 billion, Procter & Gamble Company (The) continued to prioritize capital returns and strategic reinvestment amidst a dynamic economic landscape.

Financial Highlights

* Net Sales: $84.3 billion

* Net Earnings: $14.1 billion

* Diluted Earnings Per Share: $6.51

* Core Earnings Per Share: $6.83

* Operating Cash Flow: $17.8 billion

* Adjusted Free Cash Flow Productivity: 87%

* Dividends Paid: $9.9 billion

* Share Repurchases: $4.5 billion

Procter & Gamble Company (The) operates under a comprehensive Integrated Growth Strategy built on five pillars: a focused portfolio, superiority in product and packaging, productivity, constructive disruption,... Sign in / Sign up to learn more about Procter & Gamble Company (The)

Continue your research by chatting with our AI financial analyst about Procter & Gamble Company (The). Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• In FY2025, Procter & Gamble Company (The) achieved 2% organic sales growth despite flat net sales. What does the breakdown of this growth—1% from pricing and 1% from volume—suggest about the effectiveness of its pricing strategy versus its ability to maintain market share?
• Procter & Gamble Company (The) returned over $16 billion to shareholders in FY2025. Considering its flat top-line performance, how should an analyst assess this capital allocation policy in terms of balancing immediate shareholder value with long-term investment for growth?
• The FY2025 results for Procter & Gamble Company (The) show divergent performance, with the Baby Care segment declining while the Family Care segment grew mid-single digits. How does this disparity reflect the competitive pressures and consumer trends within its core product categories?
• The bear case for Procter & Gamble Company (The) cites pressure from private labels. How effectively is the company's 'Integrated Growth Strategy,' specifically its pillars of 'Superiority' and 'Productivity,' defending its premium positioning and margins against these lower-cost competitors?
• With an upcoming CEO transition, what are the key strategic challenges and opportunities the incoming leadership of Procter & Gamble Company (The) will face, particularly concerning the 'constructive disruption' pillar of its strategy and the need to accelerate top-line growth?